交易 Galera Therapeutics, Inc. - GRTX CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | 0.0113 | ||||||||
多頭倉位隔夜費用
多頭倉位隔夜費用
前往平台 | -0.026151% | ||||||||
空頭倉位隔夜費用
空頭倉位隔夜費用
前往平台 | 0.003929% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Galera Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Sep 22, 2023 | 0.1715 | 0.0014 | 0.82% | 0.1701 | 0.1741 | 0.1670 |
Sep 21, 2023 | 0.1689 | -0.0178 | -9.53% | 0.1867 | 0.1867 | 0.1675 |
Sep 20, 2023 | 0.1843 | -0.0202 | -9.88% | 0.2045 | 0.2045 | 0.1807 |
Sep 19, 2023 | 0.1980 | 0.0035 | 1.80% | 0.1945 | 0.2280 | 0.1945 |
Sep 18, 2023 | 0.1841 | -0.0019 | -1.02% | 0.1860 | 0.1878 | 0.1831 |
Sep 15, 2023 | 0.1816 | -0.0044 | -2.37% | 0.1860 | 0.1876 | 0.1805 |
Sep 14, 2023 | 0.1848 | -0.0012 | -0.65% | 0.1860 | 0.1921 | 0.1845 |
Sep 13, 2023 | 0.1885 | 0.0019 | 1.02% | 0.1866 | 0.1948 | 0.1855 |
Sep 12, 2023 | 0.1878 | -0.0004 | -0.21% | 0.1882 | 0.1933 | 0.1845 |
Sep 11, 2023 | 0.1880 | -0.0022 | -1.16% | 0.1902 | 0.1941 | 0.1856 |
Sep 4, 2023 | 2.1500 | 0.0000 | 0.00% | 2.1500 | 2.1500 | 2.1500 |
Aug 22, 2023 | 2.1500 | 0.0000 | 0.00% | 2.1500 | 2.1500 | 2.1500 |
Aug 9, 2023 | 2.1500 | 0.0700 | 3.37% | 2.0800 | 2.2400 | 2.0000 |
Aug 8, 2023 | 2.0400 | 0.1000 | 5.15% | 1.9400 | 2.0700 | 1.8900 |
Aug 7, 2023 | 2.1000 | -0.1000 | -4.55% | 2.2000 | 2.2000 | 2.0500 |
Aug 4, 2023 | 2.1600 | -0.0200 | -0.92% | 2.1800 | 2.2600 | 2.0700 |
Aug 3, 2023 | 2.1600 | 0.1400 | 6.93% | 2.0200 | 2.3200 | 2.0000 |
Aug 2, 2023 | 2.0600 | -0.1200 | -5.50% | 2.1800 | 2.1800 | 2.0300 |
Aug 1, 2023 | 2.1900 | -0.2000 | -8.37% | 2.3900 | 2.4000 | 2.1700 |
Jul 31, 2023 | 2.3900 | -0.2388 | -9.08% | 2.6288 | 2.6387 | 2.3757 |
Galera Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, November 7, 2023 | ||
时间(协调世界时) (UTC) 13:30 | 國家 US
| 事件 Q3 2023 Galera Therapeutics Inc Earnings Release Q3 2023 Galera Therapeutics Inc Earnings ReleaseForecast(預報) -上一頁 - |
Wednesday, March 6, 2024 | ||
时间(协调世界时) (UTC) 13:30 | 國家 US
| 事件 Q4 2023 Galera Therapeutics Inc Earnings Release Q4 2023 Galera Therapeutics Inc Earnings ReleaseForecast(預報) -上一頁 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 51.226 | 73.368 | 70.553 | 50.691 | 24.255 |
銷售/一般/行政費用,總計 | 20.214 | 20.951 | 15.708 | 8.358 | 5.592 |
研究與開發 | 31.012 | 52.417 | 54.845 | 42.333 | 18.663 |
營業收入 | -51.226 | -73.368 | -70.553 | -50.691 | -24.255 |
利息收入(費用),非經營淨值 | -11.066 | -7.166 | -3.681 | -1.248 | 0.356 |
稅前淨收入 | -62.292 | -80.534 | -74.234 | -51.939 | -23.899 |
稅後淨收入 | -62.222 | -80.534 | -74.218 | -51.93 | -23.676 |
未計算非常項目前的淨收益 | -62.222 | -80.534 | -74.218 | -51.93 | -23.676 |
淨收入 | -62.222 | -80.534 | -74.218 | -51.93 | -23.676 |
Total Adjustments to Net Income | -7.176 | -5.91 | |||
普通股股東可獲收益 (不含非經常性項目) | -62.222 | -80.534 | -74.218 | -59.106 | -29.586 |
普通股股東可獲收益 (含非經常性項目) | -62.222 | -80.534 | -74.218 | -59.106 | -29.586 |
攤薄淨收入 | -62.222 | -80.534 | -74.218 | -59.106 | -29.586 |
攤薄後加權平均股 | 27.0867 | 25.7895 | 24.8698 | 24.8116 | 24.3621 |
扣除特別項目的每股攤薄盈利 | -2.29715 | -3.12275 | -2.98427 | -2.3822 | -1.21443 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -2.29715 | -3.12275 | -2.98427 | -2.3822 | -1.21443 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 16.807 | 13.881 | 13.158 | 12.959 | 11.929 |
銷售/一般/行政費用,總計 | 9.246 | 6.609 | 5.021 | 4.853 | 5.293 |
研究與開發 | 7.561 | 7.272 | 8.137 | 8.106 | 6.636 |
營業收入 | -16.807 | -13.881 | -13.158 | -12.959 | -11.929 |
利息收入(費用),非經營淨值 | -3.905 | -3.829 | -3.073 | -3.075 | -2.629 |
稅前淨收入 | -20.712 | -17.71 | -16.258 | -16.033 | -14.558 |
稅後淨收入 | -20.712 | -17.71 | -16.188 | -16.033 | -14.558 |
未計算非常項目前的淨收益 | -20.712 | -17.71 | -16.188 | -16.033 | -14.558 |
淨收入 | -20.712 | -17.71 | -16.188 | -16.033 | -14.558 |
普通股股東可獲收益 (不含非經常性項目) | -20.712 | -17.71 | -16.188 | -16.033 | -14.558 |
普通股股東可獲收益 (含非經常性項目) | -20.712 | -17.71 | -16.188 | -16.033 | -14.558 |
攤薄淨收入 | -20.712 | -17.71 | -16.188 | -16.033 | -14.558 |
攤薄後加權平均股 | 42.917 | 35.1961 | 27.9516 | 26.8235 | 26.8213 |
扣除特別項目的每股攤薄盈利 | -0.48261 | -0.50318 | -0.57914 | -0.59772 | -0.54278 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.48261 | -0.50318 | -0.57852 | -0.59776 | -0.54278 |
Gain (Loss) on Sale of Assets | -0.027 | 0.001 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 38.535 | 77.392 | 77.929 | 117.57 | 83.852 |
現金和短期投資 | 31.597 | 71.217 | 72.776 | 112.29 | 81.517 |
現金等價物 | 4.266 | 19.859 | 15.872 | 18.356 | 14.811 |
短期投資 | 27.331 | 51.358 | 56.904 | 93.934 | 66.706 |
應收賬款總額,淨額 | 0 | 0.87 | |||
預付的費用 | 3.646 | 6.175 | 5.153 | 5.28 | 1.465 |
總資産 | 44.036 | 83.311 | 84.098 | 123.376 | 88.056 |
物業/廠房/設備,總計 - 淨額 | 0.481 | 0.823 | 1.553 | 1.749 | 0.568 |
物業/廠房/設備,總計 - 總額 | 2.182 | 2.41 | 2.362 | 2.19 | 0.775 |
累計折舊,總計 | -1.701 | -1.587 | -0.809 | -0.441 | -0.207 |
商譽,淨額 | 0.881 | 0.881 | 0.881 | 0.881 | 0.881 |
無形資産,淨額 | 2.258 | 2.258 | 2.258 | 2.258 | 2.258 |
其他長期資産,總計 | 1.881 | 1.957 | 1.477 | 0.918 | 0.497 |
流動負債總額 | 13.379 | 12.935 | 13.968 | 9.694 | 6.444 |
應付賬款 | 3.581 | 5.044 | 5.146 | 3.945 | 3.867 |
預提費用 | 9.798 | 7.891 | 8.822 | 5.749 | 2.577 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 153.217 | 141.315 | 77.98 | 53.768 | 26.974 |
長期債務總額 | 139.635 | 128.063 | 63.369 | 43.251 | 20.22 |
長期債務 | 139.635 | 128.063 | 63.369 | 43.251 | 20.22 |
遞延所得稅 | 0.203 | 0.273 | 0.273 | 0.289 | 0.298 |
其他負債,總計 | 0 | 0.044 | 0.37 | 0.534 | 0.012 |
總權益 | -109.181 | -58.004 | 6.118 | 69.608 | 61.082 |
Redeemable Preferred Stock | 0 | ||||
普通股 | 0.028 | 0.026 | 0.025 | 0.025 | 0 |
留存收益(累計赤字) | -378.324 | -316.102 | -235.568 | -161.35 | -104.823 |
其他權益,總計 | -0.022 | -0.014 | 0.012 | 0.038 | 0.003 |
總負債和股東權益 | 44.036 | 83.311 | 84.098 | 123.376 | 88.056 |
已發行普通股總數 | 28.5101 | 26.4588 | 24.9761 | 24.8116 | 24.3621 |
Preferred Stock - Non Redeemable, Net | 165.902 | ||||
額外實收資本 | 269.137 | 258.086 | 241.649 | 230.895 | |
其他流動資産,總計 | 3.292 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流動資産總額 | 54.243 | 38.535 | 44.917 | 55.188 | 65.276 |
現金和短期投資 | 47.751 | 31.597 | 42.769 | 52.007 | 60.947 |
現金等價物 | 25.687 | 4.266 | 12.73 | 17.376 | 19.645 |
短期投資 | 22.064 | 27.331 | 30.039 | 34.631 | 41.302 |
預付的費用 | 3.2 | 3.646 | 2.098 | 3.181 | 4.329 |
總資産 | 59.714 | 44.036 | 50.713 | 61.078 | 71.099 |
物業/廠房/設備,總計 - 淨額 | 0.418 | 0.481 | 0.57 | 0.654 | 0.738 |
物業/廠房/設備,總計 - 總額 | 1.869 | 2.182 | 2.246 | 2.302 | 2.357 |
累計折舊,總計 | -1.451 | -1.701 | -1.676 | -1.648 | -1.619 |
商譽,淨額 | 0.881 | 0.881 | 0.881 | 0.881 | 0.881 |
無形資産,淨額 | 2.258 | 2.258 | 2.258 | 2.258 | 2.258 |
其他長期資産,總計 | 1.914 | 1.881 | 2.087 | 2.097 | 1.946 |
流動負債總額 | 13.266 | 13.379 | 11.632 | 10.986 | 10.931 |
應付賬款 | 5.937 | 3.581 | 3.591 | 3.588 | 4.131 |
預提費用 | 7.329 | 9.798 | 8.041 | 7.398 | 6.8 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 157.327 | 153.217 | 148.215 | 144.324 | 141.57 |
長期債務總額 | 143.858 | 139.635 | 136.31 | 133.065 | 130.366 |
長期債務 | 143.858 | 139.635 | 136.31 | 133.065 | 130.366 |
遞延所得稅 | 0.203 | 0.203 | 0.273 | 0.273 | 0.273 |
其他負債,總計 | 0 | 0 | 0 | 0 | |
總權益 | -97.613 | -109.181 | -97.502 | -83.246 | -70.471 |
普通股 | 0.043 | 0.028 | 0.027 | 0.027 | 0.027 |
額外實收資本 | 298.362 | 269.137 | 264.7 | 262.94 | 261.108 |
留存收益(累計赤字) | -396.034 | -378.324 | -362.136 | -346.103 | -331.545 |
其他權益,總計 | 0.016 | -0.022 | -0.093 | -0.11 | -0.061 |
總負債和股東權益 | 59.714 | 44.036 | 50.713 | 61.078 | 71.099 |
已發行普通股總數 | 42.9068 | 28.5101 | 26.4388 | 26.8216 | 26.8194 |
應收賬款總額,淨額 | |||||
Redeemable Preferred Stock | 0 | ||||
其他流動資産,總計 | 3.292 | 3.292 | 0.05 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -62.222 | -80.534 | -74.218 | -51.93 | -23.676 |
經營活動産生的現金 | -43.426 | -67.958 | -59.537 | -46.661 | -22.166 |
經營活動産生的現金 | 0.114 | 0.778 | 0.368 | 0.267 | 0.127 |
Deferred Taxes | -0.07 | 0 | -0.016 | -0.009 | -0.223 |
非現金物品 | 15.493 | 14.425 | 10.416 | 5.666 | 1.083 |
營運資金的變化 | 3.259 | -2.627 | 3.913 | -0.655 | 0.523 |
投資活動産生的現金 | 23.994 | 5.238 | 36.547 | -27.825 | -59.036 |
資本支出 | -0.025 | -0.283 | -0.457 | -0.633 | -0.347 |
其他投資現金流量項目,總計 | 24.019 | 5.521 | 37.004 | -27.192 | -58.689 |
融資活動産生的現金 | 3.889 | 66.707 | 20.506 | 78.031 | 89.844 |
融資現金流項目 | 0 | 69.844 | |||
債務的發行(退還),淨額 | 0 | 57.5 | 20 | 20 | 20 |
現金淨變化 | -15.543 | 3.987 | -2.484 | 3.545 | 8.642 |
股票的發行(報廢),淨額 | 3.889 | 9.207 | 0.506 | 58.031 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -17.71 | -62.222 | -46.034 | -30.001 | -15.443 |
Cash From Operating Activities | -11.666 | -43.426 | -29.481 | -20.271 | -11.385 |
Cash From Operating Activities | 0.02 | 0.114 | 0.088 | 0.061 | 0.031 |
Non-Cash Items | 5.681 | 15.493 | 13.675 | 8.68 | 4.151 |
Changes in Working Capital | 0.343 | 3.259 | 2.79 | 0.989 | -0.124 |
Cash From Investing Activities | 5.305 | 23.994 | 21.215 | 16.611 | 9.996 |
Capital Expenditures | 0 | -0.025 | -0.025 | -0.02 | -0.013 |
Other Investing Cash Flow Items, Total | 5.305 | 24.019 | 21.24 | 16.631 | 10.009 |
Cash From Financing Activities | 27.782 | 3.889 | 1.187 | 1.177 | 1.175 |
Issuance (Retirement) of Stock, Net | 27.782 | 3.889 | 1.187 | 1.177 | 1.175 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | ||
Net Change in Cash | 21.421 | -15.543 | -7.079 | -2.483 | -0.214 |
Deferred Taxes | -0.07 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
45 Liberty Blvd.
Suite 230
MALVERN
PENNSYLVANIA 19355
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 555.000 多名交易者,選擇與 Capital.com 交易